 | • レポートコード：D005-00701 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、単因性疾患テストの世界市場を広く調査・分析し、今後の市場展望をまとめております。単因性疾患テストの種類別市場規模（保因者検査、診断検査、新生児スクリーニング、予測および症状前検査、出生前検査、その他）、用途別市場規模（病院、専門クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Celera Group、Roche、ELITech Group、Abbott、PerkinElmer、Thermo Fisher Scientific、Transgenomic、AutoGenomics、Quest、Bio-Rad ・地域別グローバル市場分析 2015年-2020年 ・単因性疾患テストの北米市場（アメリカ、カナダ、メキシコ） ・単因性疾患テストのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・単因性疾患テストのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・単因性疾患テストの南米市場（ブラジル、アルゼンチン） ・単因性疾患テストの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：保因者検査、診断検査、新生児スクリーニング、予測および症状前検査、出生前検査、その他 ・用途別分析：病院、専門クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Monogenetic Disorders Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Monogenetic Disorders Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Monogenetic Disorders Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Monogenetic Disorders Testing market has been segmented into:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
By Application, Monogenetic Disorders Testing has been segmented into:
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Monogenetic Disorders Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Monogenetic Disorders Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monogenetic Disorders Testing market.
The report offers in-depth assessment of the growth and other aspects of the Monogenetic Disorders Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Monogenetic Disorders Testing Market Share Analysis
Monogenetic Disorders Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Monogenetic Disorders Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monogenetic Disorders Testing sales, revenue and market share for each player covered in this report.
The major players covered in Monogenetic Disorders Testing are:
Celera Group
Roche
ELITech Group
Abbott
PerkinElmer
Thermo Fisher Scientific
Transgenomic
AutoGenomics
Quest
Bio-Rad
Table of Contents
1 Monogenetic Disorders Testing Market Overview
1.1 Product Overview and Scope of Monogenetic Disorders Testing
1.2 Classification of Monogenetic Disorders Testing by Type
1.2.1 Global Monogenetic Disorders Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Monogenetic Disorders Testing Revenue Market Share by Type in 2019
1.2.3 Carrier Testing
1.2.4 Diagnostic Testing
1.2.5 New-Born Screening
1.2.6 Predictive & Pre-Symptomatic Testing
1.2.7 Prenatal Testing
1.2.8 Others
1.3 Global Monogenetic Disorders Testing Market by Application
1.3.1 Overview: Global Monogenetic Disorders Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Monogenetic Disorders Testing Market by Regions
1.4.1 Global Monogenetic Disorders Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Monogenetic Disorders Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Monogenetic Disorders Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Monogenetic Disorders Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monogenetic Disorders Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Celera Group
2.1.1 Celera Group Details
2.1.2 Celera Group Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Celera Group SWOT Analysis
2.1.4 Celera Group Product and Services
2.1.5 Celera Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 ELITech Group
2.3.1 ELITech Group Details
2.3.2 ELITech Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ELITech Group SWOT Analysis
2.3.4 ELITech Group Product and Services
2.3.5 ELITech Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 PerkinElmer SWOT Analysis
2.5.4 PerkinElmer Product and Services
2.5.5 PerkinElmer Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Transgenomic
2.7.1 Transgenomic Details
2.7.2 Transgenomic Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Transgenomic SWOT Analysis
2.7.4 Transgenomic Product and Services
2.7.5 Transgenomic Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 AutoGenomics
2.8.1 AutoGenomics Details
2.8.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AutoGenomics SWOT Analysis
2.8.4 AutoGenomics Product and Services
2.8.5 AutoGenomics Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Quest
2.9.1 Quest Details
2.9.2 Quest Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Quest SWOT Analysis
2.9.4 Quest Product and Services
2.9.5 Quest Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad
2.10.1 Bio-Rad Details
2.10.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad SWOT Analysis
2.10.4 Bio-Rad Product and Services
2.10.5 Bio-Rad Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Monogenetic Disorders Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Monogenetic Disorders Testing Players Market Share
3.2.2 Top 10 Monogenetic Disorders Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Monogenetic Disorders Testing Revenue and Market Share by Regions
4.2 North America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
4.5 South America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
5 North America Monogenetic Disorders Testing Revenue by Countries
5.1 North America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
5.2 USA Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
6 Europe Monogenetic Disorders Testing Revenue by Countries
6.1 Europe Monogenetic Disorders Testing Revenue by Countries (2015-2020)
6.2 Germany Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
6.3 UK Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
6.4 France Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries
7.1 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries (2015-2020)
7.2 China Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
7.5 India Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
8 South America Monogenetic Disorders Testing Revenue by Countries
8.1 South America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
8.2 Brazil Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Monogenetic Disorders Testing by Countries
9.1 Middle East & Africa Monogenetic Disorders Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Monogenetic Disorders Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Monogenetic Disorders Testing Market Forecast by Type (2019-2024)
10.3 Carrier Testing Revenue Growth Rate (2015-2025)
10.4 Diagnostic Testing Revenue Growth Rate (2015-2025)
10.5 New-Born Screening Revenue Growth Rate (2015-2025)
10.6 Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2015-2025)
10.7 Prenatal Testing Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Monogenetic Disorders Testing Market Segment by Application
11.1 Global Monogenetic Disorders Testing Revenue Market Share by Application (2015-2020)
11.2 Monogenetic Disorders Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Specialized Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)
12.1 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)
12.2 Global Monogenetic Disorders Testing Market Forecast by Regions (2021-2025)
12.3 North America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
12.4 Europe Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
12.6 South America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Monogenetic Disorders Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Monogenetic Disorders Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Monogenetic Disorders Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Monogenetic Disorders Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Celera Group Corporate Information, Location and Competitors
Table 6. Celera Group Monogenetic Disorders Testing Major Business
Table 7. Celera Group Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 8. Celera Group SWOT Analysis
Table 9. Celera Group Monogenetic Disorders Testing Product and Solutions
Table 10. Celera Group Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche Monogenetic Disorders Testing Major Business
Table 13. Roche Monogenetic Disorders Testing Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche Monogenetic Disorders Testing Product and Solutions
Table 16. Roche Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. ELITech Group Corporate Information, Location and Competitors
Table 18. ELITech Group Monogenetic Disorders Testing Major Business
Table 19. ELITech Group Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 20. ELITech Group SWOT Analysis
Table 21. ELITech Group Monogenetic Disorders Testing Product and Solutions
Table 22. ELITech Group Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott Monogenetic Disorders Testing Major Business
Table 25. Abbott Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott Monogenetic Disorders Testing Product and Solutions
Table 28. Abbott Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. PerkinElmer Corporate Information, Location and Competitors
Table 30. PerkinElmer Monogenetic Disorders Testing Major Business
Table 31. PerkinElmer Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 32. PerkinElmer SWOT Analysis
Table 33. PerkinElmer Monogenetic Disorders Testing Product and Solutions
Table 34. PerkinElmer Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Monogenetic Disorders Testing Major Business
Table 37. Thermo Fisher Scientific Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Monogenetic Disorders Testing Product and Solutions
Table 40. Thermo Fisher Scientific Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Transgenomic Corporate Information, Location and Competitors
Table 42. Transgenomic Monogenetic Disorders Testing Major Business
Table 43. Transgenomic Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 44. Transgenomic SWOT Analysis
Table 45. Transgenomic Monogenetic Disorders Testing Product and Solutions
Table 46. Transgenomic Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AutoGenomics Corporate Information, Location and Competitors
Table 48. AutoGenomics Monogenetic Disorders Testing Major Business
Table 49. AutoGenomics Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 50. AutoGenomics SWOT Analysis
Table 51. AutoGenomics Monogenetic Disorders Testing Product and Solutions
Table 52. AutoGenomics Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Quest Corporate Information, Location and Competitors
Table 54. Quest Monogenetic Disorders Testing Major Business
Table 55. Quest Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 56. Quest SWOT Analysis
Table 57. Quest Monogenetic Disorders Testing Product and Solutions
Table 58. Quest Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bio-Rad Corporate Information, Location and Competitors
Table 60. Bio-Rad Monogenetic Disorders Testing Major Business
Table 61. Bio-Rad Monogenetic Disorders Testing Total Revenue (USD Million) (2017-2018)
Table 62. Bio-Rad SWOT Analysis
Table 63. Bio-Rad Monogenetic Disorders Testing Product and Solutions
Table 64. Bio-Rad Monogenetic Disorders Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Monogenetic Disorders Testing Revenue (Million USD) by Players (2015-2020)
Table 66. Global Monogenetic Disorders Testing Revenue Share by Players (2015-2020)
Table 67. Global Monogenetic Disorders Testing Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Monogenetic Disorders Testing Revenue Market Share by Regions (2015-2020)
Table 69. North America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
Table 70. North America Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Table 71. Europe Monogenetic Disorders Testing Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Monogenetic Disorders Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
Table 74. South America Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Monogenetic Disorders Testing Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Table 77. Global Monogenetic Disorders Testing Revenue (Million USD) by Type (2015-2020)
Table 78. Global Monogenetic Disorders Testing Revenue Share by Type (2015-2020)
Table 79. Global Monogenetic Disorders Testing Revenue Forecast by Type (2021-2025)
Table 80. Global Monogenetic Disorders Testing Revenue by Application (2015-2020)
Table 81. Global Monogenetic Disorders Testing Revenue Share by Application (2015-2020)
Table 82. Global Monogenetic Disorders Testing Revenue Forecast by Application (2021-2025)
Table 83. Global Monogenetic Disorders Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Monogenetic Disorders Testing Picture
Figure 2. Global Monogenetic Disorders Testing Revenue Market Share by Type in 2019
Figure 3. Carrier Testing Picture
Figure 4. Diagnostic Testing Picture
Figure 5. New-Born Screening Picture
Figure 6. Predictive & Pre-Symptomatic Testing Picture
Figure 7. Prenatal Testing Picture
Figure 8. Others Picture
Figure 9. Monogenetic Disorders Testing Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Specialized Clinics Picture
Figure 12. Ambulatory Surgical Centers Picture
Figure 13. Global Monogenetic Disorders Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Monogenetic Disorders Testing Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Monogenetic Disorders Testing Revenue Market Share in 2019
Figure 22. Global Top 10 Players Monogenetic Disorders Testing Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Monogenetic Disorders Testing Revenue Market Share by Regions (2015-2020)
Figure 26. Global Monogenetic Disorders Testing Revenue Market Share by Regions in 2018
Figure 27. North America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 28. Europe Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 30. South America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 32. North America Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Figure 33. North America Monogenetic Disorders Testing Revenue Market Share by Countries in 2019
Figure 34. USA Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 35. Canada Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 37. Europe Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Monogenetic Disorders Testing Revenue Market Share by Countries in 2019
Figure 39. Germany Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 40. UK Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 41. France Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 42. Russia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 43. Italy Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Monogenetic Disorders Testing Revenue Market Share by Countries in 2019
Figure 46. China Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 47. Japan Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 48. Korea Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 49. India Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 51. South America Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Figure 52. South America Monogenetic Disorders Testing Revenue Market Share by Countries in 2019
Figure 53. Brazil Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 58. UAE Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
Figure 61. Global Monogenetic Disorders Testing Revenue Share by Type (2015-2020)
Figure 62. Global Monogenetic Disorders Testing Revenue Share by Type in 2019
Figure 63. Global Monogenetic Disorders Testing Market Share Forecast by Type (2021-2025)
Figure 64. Global Carrier Testing Revenue Growth Rate (2015-2020)
Figure 65. Global Diagnostic Testing Revenue Growth Rate (2015-2020)
Figure 66. Global New-Born Screening Revenue Growth Rate (2015-2020)
Figure 67. Global Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2015-2020)
Figure 68. Global Prenatal Testing Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Monogenetic Disorders Testing Revenue Share by Application (2015-2020)
Figure 71. Global Monogenetic Disorders Testing Revenue Share by Application in 2019
Figure 72. Global Monogenetic Disorders Testing Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Specialized Clinics Revenue Growth Rate (2015-2020)
Figure 75. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 76. Global Monogenetic Disorders Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Monogenetic Disorders Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Monogenetic Disorders Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
Figure 80. Europe Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
Figure 82. South America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
豚用診断テストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Swine Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Swine Diagnostic Tes…- がん検査/スクリーニングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Testing/Scree…
- トリコモナス迅速検査の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Trichomonas Rapid Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Trichomonas Rapid T…
- 前期破水（PROM）テストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Premature Rupture of Membranes (PROM) Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…
- 微生物検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bacteriological Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 11100 million by 2025, from USD 9406.5 million in 2019. The Bacteriologic…